May 09, 2023 / 01:00PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin First Quarter 2023 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Carlo Rosa - DiaSorin S.p.A. - CEO, GM & Executive Director
Yes. Thank you, operator. Good morning, and welcome to the DiaSorin Quarter One 2023 results. As usual, I'm going to make my comments at a constant exchange rate, and then I will allow our CFO, Mr. Pedron then to go through the numbers in great detail.
Let's start from the revenues, EUR 284 million, which is -- versus Q1 of 2022. Let's remember that there has been a change of perimeter since we have sold our Flow Cytometry business. So at constant perimeter business would be down 20%. And then there is a second factor that is clearly, COVID. COVID is down 80%, give or take, compared to what we had last year. So excluding also the COVID business and the effect of the respiratory season, which is a
Q1 2023 DiaSorin SpA Earnings Call Transcript
May 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers